| SC 13G/A | 2021-02-16 | Cormorant Asset Management, LP | CONSTELLATION PHARMACEUTICALS INC | 0 | - | EDGAR |
| SC 13G/A | 2021-02-16 | GREAT POINT PARTNERS LLC | CONSTELLATION PHARMACEUTICALS INC | 1,024,800 | 2.2% | EDGAR |
| SC 13G/A | 2021-02-16 | COLUMN GROUP L P | CONSTELLATION PHARMACEUTICALS INC | 2,584,957 | 5.4% | EDGAR |
| SC 13G/A | 2021-02-16 | Bain Capital Life Sciences Fund, L.P. | CONSTELLATION PHARMACEUTICALS INC | 1,270,003 | 2.7% | EDGAR |
| SC 13G/A | 2021-02-16 | THIRD ROCK VENTURES LP | CONSTELLATION PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-12 | Avoro Capital Advisors LLC | CONSTELLATION PHARMACEUTICALS INC | 2,950,000 | 6.2% | EDGAR |
| SC 13G | 2021-02-04 | WELLINGTON MANAGEMENT GROUP LLP | CONSTELLATION PHARMACEUTICALS INC | 4,394,543 | 9.2% | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | CONSTELLATION PHARMACEUTICALS INC | 2,596,599 | 5.5% | EDGAR |
| SC 13G | 2021-02-01 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | CONSTELLATION PHARMACEUTICALS INC | 737,406 | 1.5% | EDGAR |
| SC 13G/A | 2020-06-24 | COLUMN GROUP L P | CONSTELLATION PHARMACEUTICALS INC | 2,584,957 | 5.4% | EDGAR |
| SC 13G | 2020-06-05 | GREAT POINT PARTNERS LLC | CONSTELLATION PHARMACEUTICALS INC | 2,301,457 | 5.5% | EDGAR |
| SC 13G/A | 2020-02-14 | Cormorant Asset Management, LP | CONSTELLATION PHARMACEUTICALS INC | 1,353,094 | - | EDGAR |
| SC 13G/A | 2020-02-14 | VENROCK ASSOCIATES V LP | CONSTELLATION PHARMACEUTICALS INC | 1,740,945 | 4.2% | EDGAR |
| SC 13G | 2020-02-14 | Avoro Capital Advisors LLC | CONSTELLATION PHARMACEUTICALS INC | 3,650,000 | 8.8% | EDGAR |
| SC 13G | 2020-02-14 | REGENTS OF THE UNIVERSITY OF CALIFORNIA | CONSTELLATION PHARMACEUTICALS INC | 1,747,406,000 | 5.2% | EDGAR |
| SC 13G/A | 2020-02-07 | FMR LLC | CONSTELLATION PHARMACEUTICALS INC | 1,581,715 | 3.9% | EDGAR |
| SC 13G/A | 2020-02-06 | Casdin Capital, LLC | CONSTELLATION PHARMACEUTICALS INC | 1,212,734 | 2.9% | EDGAR |
| SC 13G | 2019-11-18 | Cormorant Asset Management, LP | CONSTELLATION PHARMACEUTICALS INC | 766,048 | - | EDGAR |
| SC 13G | 2019-10-11 | Bain Capital Life Sciences Fund, L.P. | CONSTELLATION PHARMACEUTICALS INC | 2,561,350 | 7.7% | EDGAR |
| SC 13G/A | 2019-10-10 | COLUMN GROUP L P | CONSTELLATION PHARMACEUTICALS INC | 2,584,957 | 7.7% | EDGAR |